In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Geron Corporation's RYTELO gains FDA approval for Low-Risk MDS, with strong sales projections and promising Phase 3 study.

Let’s talk iron. While pumping iron is one of many athletic pursuits, it doesn’t go well when your body’s iron stores are ...

To better understand the benefits and risks associated with lymphatic drainage massages, we got the inside scoop from Rebecca ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow.

Hemangiosarcoma (HSA) is a particularly aggressive form of cancer that begins in the cells lining the blood vessels. It ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The prion disease that causes deer, elk and other cervids to waste away could someday jump to humans, but many hunters are ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

His running has taken him to such prestigious marathons as New York City four times, Big Sur in California four times, ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of ...